Search
Ondansetron
go.drugbank.com/drugs/DB00904ApprovedInvestigationalWithdrawn[L5221] The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation. … and use, including the development of orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: MYLAN ONDANSETRON CONCENTRATE FOR SOLUTION FOR INFUSION OR INJECTION 2MG/ML, BRAUN SOLUTION FOR INJECTION OR INFUSION 2 MG/MLKanamycin
go.drugbank.com/drugs/DB01172ApprovedInvestigationalVet approvedWithdrawnKanamycin is isolated from the bacterium Streptomyces kanamyceticus and its most commonly used form is kanamycin sulfate. … Kanamycin (also known as kanamycin A) is an aminoglycoside bacteriocidal antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: KANAMYCIN MEIJI FOR INJECTION 1 g/vialEdetate disodium anhydrous
go.drugbank.com/drugs/DB14600ApprovedInvestigationalVet approvedEdetate disodium anhydrous is a polyvalent chelating agent used to treat hypercalcemia and digitalis toxicity associated ventricular arrhythmias.[A204275]
Synonyms: EDTA disodium salt (anhydrous)Ephedrine
go.drugbank.com/drugs/DB01364ApprovedInvestigational[L12972] Ephedrine and [phenylephrine] are still used to treat hypotension, but their use in other indications has decreased due to the development of more selective adrenergic agonists. … [A193650,L12972] Ephedrine is used for its vasoconstrictive, positive chronotropic, and positive inotropic effects.
Mixtures: WICK MediNait Erkältungssirup für die NachtCategories: Adrenergics for Systemic Use, Drugs for Obstructive Airway DiseasesSalmeterol
go.drugbank.com/drugs/DB00938ApprovedInvestigationalSalmeterol is a long-acting beta-2 adrenergic receptor agonist drug that is currently prescribed for the treatment of asthma and chronic obstructive pulmonary disease COPD. … [A190477] Salmeterol's structure is similar to salbutamol's with an aralkyloxy-alkyl substitution on the amine.[A183737] Salmeterol was granted FDA approval on 4 February 1994.[L11542]
Mixtures: HOVID CLEFAN-S POWDER FOR INHALATION 50/250MCG, AIRFLUSAL FORSPIRO POWDER FOR INHALATION 50MCG/500MCGCategories: Agents to Treat Airway Disease, Drugs for Obstructive Airway DiseasesHypromellose
go.drugbank.com/drugs/DB11075ApprovedInvestigationalIt is a commonly used as a delivery component in oral pharmaceutical products that provides the release of a drug in a controlled fashion, effectively increasing the duration of release of a drug to prolong … Hypromellose, or hydroxypropyl methylcellulose (HPMC) [L1812], is a semisynthetic, inert, and viscoelastic polymer that forms a colloid solution when dissolved in water.
Mixtures: GenTeal Moderate to Severe, Visine for Dry Eye True TearsCategories: Compounds used in a research, industrial, or household settingL-arginine
go.drugbank.com/drugs/DB17289ApprovedInvestigationalNutraceuticalMixtures: AMINOVEN SOLUTION FOR INFUSION 15%Products: LYSAKARE SOLUTION FOR INFUSION 25G / 25GClotrimazole
go.drugbank.com/drugs/DB00257ApprovedInvestigationalVet approvedThe minimal side effect profile of this drug and its uncomplicated metabolic profile have led it to gain widespread acceptance for the treatment of mycotic outbreaks such as vaginal yeast infections as … This drug is a broad spectrum antimycotic or antifungal agent. Clotrimazole's antimycotic properties were discovered in the late 1960s [A174094].
Mixtures: TOR CREMA DERMATOLOGICA, Extra Strength Clotrimazole Extra Fort -fluconazole CombiCategories: Antifungals for Topical Use, Antifungals for Dermatological UseGalsulfase
go.drugbank.com/drugs/DB01279ApprovedInvestigationalThe recombinant protein is comprised of 495 amino acids and contains six asparagine-linked glycosylation sites, four of which carry a bis mannose-6-phosphate manose7 oligosaccharide for specific cellular … Post-translational modification of Cys53 produces the catalytic amino acid residue Ca-formylglycine, which is required for enzyme activity and is conserved in all members of the sulfatase enzyme family
Products: Naglazyme Concentrated Solution for Intravenous Infusion 1mg/1ml